Our study also found that tumor-promoting CAFs with high itgb2 expression can activate the PI3K/AKT/mTOR axis, thereby promoting OSCC tumor proliferation via NADH-driven oxidative phosphorylation in mitochondria (52). The gene discussed is ITGB2; the disease is neoplasm.